Fecal transplantation has dramatically reduced the symptoms of autism in children

Researchers at Arizona State University have revealed that fecal transplants significantly reduce autism-related symptoms in children with autism spectrum disorder (ASD) over a two-year period. Study participants also found an improvement in their bowel health, highlighting the potential benefits that stool transplants could provide to people with autism spectrum disorder.

The findings were revealed in a recently published study detailing the long-term effects of microbiota transfer therapy (MTT, a form of stool graft) on the symptoms of autism spectrum disorders. According to a university announcement, parents reported a "slow and steady reduction" in these symptoms within two years of treatment.

Two years after treatment, one expert found that the "core" symptoms of autism spectrum disorder had decreased by 45%, which included categories of behavior, language and social interaction. This determination was made by comparing post-treatment symptoms with pre-treatment symptoms.

Rosa Krajmalnik-Brown, PhD, one of the researchers behind the study, explained:

We see a very strong link between the microbes that live in our intestines and the signals that go into the brain … Many children with autism have gastrointestinal problems and some studies, including ours, have shown that these children also have more serious symptoms related to autism. In many cases, when you are able to treat these gastrointestinal problems, their behavior improves.

Gastrointestinal problems affect between 30 and 50% of people with autism. Unlike previous research that found only short-term improvements in ASD symptoms and gut health through the use of an antibiotic, this latest study found benefits that increased for more than two years. years after treatment. Fecal transplants have already been badociated with weight loss in overweight people.